J. Sagar Associates (JSA) advised Monarch Networth Capital Limited and HDFC Bank Limited in relation to the qualified institutions placement of Alembic Pharmaceuticals Limited (“Alembic”). Alembic had filed a placement document on August 6, 2020 for issue of 80,47,210 equity shares to qualified institutional buyers aggregating INR 749.99 crore.
Alembic is a vertically integrated pharmaceutical company, developing, manufacturing and marketing of formulations offered in the international markets including in markets such as the United States, European Union, etc, formulations which cater to India’s domestic formulations market and active pharmaceutical ingredients which cater to both domestic and international markets.
JSA Team comprised Partner – Arka Mookerjee; Independent Senior Consultant – Madhurima Mukherjee; Principal Associate – Pracheta Bhattacharya; and Associates – Krupa Brahmbhatt, Sourav Modi and Kairav Parikh.
Arka Mookerjee is a Partner and Co-Head of the Equity Capital Markets practice, with over 21 years of experience advising on India’s most complex and high-value transactions. Widely recognised for pioneering mandates—including India’s first QIP and InvIT IPO—he represents issuers, underwriters and investors across capital markets and investment structures. Arka actively engages with regulators and industry bodies, playing a key role in shaping India’s evolving capital markets framework.